Physician profile
Nada Taleb
NPI 1659560290
$2,309.97
in general payments reported to CMS, 2019-2025
16 companies · $720 in 2025
The $720 reported for 2025 was more than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $767 · 2020: $239 · 2022: $377 · 2023: $66.13 · 2024: $142 · 2025: $720.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $928.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $927.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $567.70 | 2022-2025 | General - Pain Management, Watchman Flx, Farapulse |
| Novo Nordisk INC | $254.98 | 2020-2025 | Wegovy |
| Gilead Sciences, INC. | $192.14 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $181.54 | 2019-2022 | |
| Medtronic, INC. | $137.00 | 2022 | |
| Pfizer INC. | $133.24 | 2019 | |
| Sunovion Pharmaceuticals INC. | $124.62 | 2019 | |
| Allergan, INC. | $117.61 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $113.16 | 2019 | |
| Amarin Pharma, INC. | $110.00 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $108.27 | 2025 | |
| Si-Bone, INC. | $88.80 | 2024 | |
| Abbvie INC. | $66.13 | 2023 | Vraylar |
| Lifenet Health | $55.55 | 2025 | Allograft Vmis Delivery System, Pliafx Flo |
| Depuy Synthes Sales INC. | $54.03 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $5.20 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nada Taleb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.